Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document C2016/276/02

    Tilbagetrækning af en fusionsanmeldelse (Sag M.7917 — Boehringer Ingelheim/Sanofi Animal Health Business) (EØS-relevant tekst)

    EUT C 276 af 29.7.2016, p. 21–21 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    29.7.2016   

    DA

    Den Europæiske Unions Tidende

    C 276/21

    Tilbagetrækning af en fusionsanmeldelse

    (Sag M.7917 — Boehringer Ingelheim/Sanofi Animal Health Business)

    (EØS-relevant tekst)

    (2016/C 276/02)

    (Rådets forordning (EF) nr. 139/2004)

    Den 8. juni 2016 modtog Kommissionen en anmeldelse af en planlagt fusion mellem Boehringer Ingelheim og Sanofi Animal Health Business. Den 22. juli 2016 meddelte den (de) anmeldende part(er) Kommissionen, at den/de trak sin/deres anmeldelse tilbage.

    Top